Biological Safety Testing Products and Services encompass a range of tools, assays, and expertise used to assess the safety and quality of biopharmaceuticals and medical devices. They include tests for sterility, endotoxin levels, cell-based assays, and viral clearance studies to ensure product safety, efficacy, and compliance with regulatory standards. In terms of revenue, the global biological safety testing products and services market was worth US$ 3.47 Bn in 2022, anticipated to witness CAGR of 12.7% during 2023 – 2031.

Global Biological Safety Testing Products and Services Market Revenue & Forecast, (US$ Million), 2015 – 2031

Trends in the Global Biological Safety Testing Products and Services Market

• Currently, there is a notable trend of continuous advancement in biopharmaceutical research and development. The increasing complexity of biologics, such as monoclonal antibodies and gene therapies, demands robust biological safety testing. The ongoing development of cutting-edge therapies, particularly in areas like immuno-oncology and gene editing, necessitates rigorous safety assessments. As these innovations progress, the demand for state-of-the-art biological safety testing products and services remains high to ensure the safety and efficacy of these novel biopharmaceuticals before they reach patients.
• Presently, stringent regulatory standards and evolving compliance requirements are pivotal drivers in the biological safety testing products and services market. Regulatory agencies worldwide, such as the FDA and EMA, are continually updating and tightening safety and quality standards for biopharmaceuticals and medical devices. The ongoing trend involves a greater focus on risk-based approaches and comprehensive safety assessments. Companies are proactively investing in advanced testing products and services to meet these evolving regulatory demands, ensuring their products adhere to the highest safety and quality benchmarks, and facilitating faster market approvals.

Virus safety tests segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global biological safety testing products and services market during the forecast period. Recent years have witnessed a surge in biopharmaceuticals and vaccines, with the global vaccine market valued at over $45 billion in 2022. This trend has amplified the need for rigorous virus safety testing to ensure that biologics and vaccines are free from viral contaminants. With the emergence of advanced gene therapies and viral vectors, comprehensive testing has become imperative. Stringent regulatory guidelines, like those from the FDA and WHO, necessitate thorough virus safety assessments. This growth reflects the segment’s critical role in maintaining the safety and integrity of biopharmaceutical products and vaccines.

Vaccine development and manufacturing application segment had the highest share in the global biological safety testing products and services market in 2022. Recent years, notably during the COVID-19 pandemic, have seen an unprecedented demand for vaccines. In 2020, over 12 billion vaccine doses were administered globally. Robust safety testing is paramount to ensure vaccine efficacy and patient safety. Regulatory agencies like the FDA closely scrutinize vaccine development. This spotlight on vaccines underscores the pivotal role of Biological Safety Testing in verifying the safety and potency of vaccines, making it a cornerstone in addressing global health challenges and advancing public immunization programs.

Asia Pacific is expected to witness the highest growth rate in the biological safety testing products and services market during the forecast period. In recent years, Asia Pacific has emerged as a major player in drug development, with countries like China and India making significant strides. The region’s pharmaceutical market was valued at over $350 billion in 2022. As pharmaceutical manufacturing expands, so does the need for rigorous safety testing. Regulatory bodies across Asia Pacific are aligning with international standards, necessitating robust safety assessments. This trend underscores the region’s pivotal role in global pharmaceutical innovation and its increasing contribution to the biological safety testing products and services market.

Report Coverage & Deliverables

Competitive Landscape

Some of the players operating in the biological safety testing products and services market are

• ASSOCIATES OF CAPE COD, INC.
• BIOMERIEUX
• Charles River Laboratories
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• GenSscript
• Laboratory Corporation of America Holdings
• Lonza
• Merck KGaA
• Samsung Biologics
• Sartorius AG
• SGS Societe Generale de Surveillance SA
• Thermo Fisher Scientific Inc.
• WuXi AppTec
• Other Industry Participants

Global Biological Safety Testing Products and Services Market Summary

 

 

Report Specifications	Details
Market Revenue in 2022	US$ 3.47 Bn
Market Size Forecast by 2031	US$ 9.89 Bn
Growth Rate (CAGR)	12.7%
Historic Data	2015 – 2021
Base Year for Estimation	2022
Forecast Period	2023 – 2031
Report Inclusions	Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered	By Product and Service, By Test Type, By Application, By End User
Regions Covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered	U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players	ASSOCIATES OF CAPE COD, INC., BIOMERIEUX, Charles River Laboratories, Eurofins Scientific, F. Hoffmann-La Roche Ltd., GenSscript, Laboratory Corporation of America Holdings, Lonza, Merck KGaA, Samsung Biologics, Sartorius AG, SGS Societe Generale de Surveillance SA, Thermo Fisher Scientific Inc., WuXi AppTec, Other Market Participants
Customization Scope	Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options	Explore purchase options tailored to your specific research requirements
Contact Details	Consult With Our Expert Japan (Toll-Free): +81 663-386-8111 South Korea (Toll-Free): +82-808-703-126 Saudi Arabia (Toll-Free): +966 800-850-1643 United Kingdom: +44 753-710-5080 United States: +1 302-232-5106 E-mail:  askanexpert@thenicheresearch.com

 

 

 

Global Biological Safety Testing Products and Services Market

By Product and Service

• Consumables
• Instruments
• Services

By Test Type

• Residual Host-Cell Proteins and DNA Detection Tests
• Mycoplasma Tests
• Endotoxin Tests
• Sterility Tests
• Bioburden Tests
• Virus Safety Tests
• Others

By Application

• Monoclonal Antibodies Development and Manufacturing
• Vaccine Development and Manufacturing
• Cellular and Gene Therapy Product Development and Manufacturing
• Blood and Blood Product Development and Manufacturing
• Other Applications

By End User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations and Contract Development and Manufacturing Organizations (CROs and CDMOs)
• Academic and Research Institutes

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

.

**Exclusive for Multi-User and Enterprise User.

Global Biological Safety Testing Products and Services Market

By Product and Service

By Test Type

By Application

By End User

By Region

**Note: The report covers cross-segmentation analysis by region further into countries

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers. Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues. Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts. Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here's a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market's evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market's historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It's crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.